Stonebridge Capital Management Inc Novartis Ag Transaction History

Stonebridge Capital Management Inc

$252 Million
Q3 2024

A detailed history of Stonebridge Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Stonebridge Capital Management Inc holds 14,775 shares of NVS stock, worth $1.63 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

14,775

Previous 14,775 -0.0%

Holding current value

$1.63 Million

Previous $1.57 Million 8.01%

% of portfolio

0.67%

Previous 0.67%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$92.57 - $107.37 $23,142 - $26,842	-250 Reduced 1.66%	14,775 $1.57 Million
Q1 2024 Apr 15, 2024	BUY	$95.27 - $108.47 $57,162 - $65,082	600 Added 4.16%	15,025 $1.45 Million
Q4 2023 Mar 05, 2024	BUY	$92.27 - $101.54 $4,613 - $5,077	50 Added 0.35%	14,425 $1.46 Million
Q3 2023 Dec 13, 2023	SELL	$94.73 - $105.13 $293,663 - $325,903	-3,100 Reduced 17.74%	14,375 $1.46 Million
Q2 2023 Jul 06, 2023	SELL	$92.52 - $104.91 $115,650 - $131,137	-1,250 Reduced 6.68%	17,475 $1.76 Million
Q1 2023 Apr 03, 2023	SELL	$80.03 - $92.81 $260,097 - $301,632	-3,250 Reduced 14.79%	18,725 $1.72 Million
Q4 2022 Jan 06, 2023	SELL	$75.55 - $92.52 $33,997 - $41,634	-450 Reduced 2.01%	21,975 $1.99 Million
Q3 2022 Oct 06, 2022	SELL	$74.61 - $87.26 $180,929 - $211,605	-2,425 Reduced 9.76%	22,425 $1.71 Million
Q2 2022 Jul 01, 2022	SELL	$80.52 - $93.75 $161,040 - $187,500	-2,000 Reduced 7.45%	24,850 $2.1 Million
Q1 2022 Apr 04, 2022	SELL	$80.11 - $90.62 $5,207 - $5,890	-65 Reduced 0.24%	26,850 $2.36 Million
Q4 2021 Jan 05, 2022	SELL	$79.7 - $88.13 $127,520 - $141,008	-1,600 Reduced 5.61%	26,915 $2.35 Million
Q1 2021 Apr 05, 2021	SELL	$83.5 - $98.47 $20,875 - $24,617	-250 Reduced 0.87%	28,515 $2.44 Million
Q4 2020 Jan 06, 2021	SELL	$78.07 - $94.43 $9,758 - $11,803	-125 Reduced 0.43%	28,765 $2.72 Million
Q3 2020 Dec 11, 2020	BUY	$82.14 - $91.0 $162,226 - $179,725	1,975 Added 7.34%	28,890 $2.51 Million
Q2 2020 Jul 07, 2020	SELL	$80.93 - $91.1 $105,209 - $118,429	-1,300 Reduced 4.61%	26,915 $2.36 Million
Q1 2020 May 20, 2020	SELL	$70.67 - $99.01 $81,270 - $113,861	-1,150 Reduced 3.92%	28,215 $2.33 Million
Q4 2019 Jan 02, 2020	SELL	$84.35 - $95.37 $16,870 - $19,074	-200 Reduced 0.68%	29,365 $2.78 Million
Q3 2019 Oct 02, 2019	SELL	$85.54 - $94.26 $614,604 - $677,258	-7,185 Reduced 19.55%	29,565 $2.57 Million
Q2 2019 Jul 12, 2019	SELL	$75.4 - $92.8 $508,573 - $625,936	-6,745 Reduced 15.51%	36,750 $3.36 Million
Q1 2019 May 02, 2019	SELL	$75.32 - $86.15 $379,989 - $434,626	-5,045 Reduced 10.39%	43,495 $4.18 Million
Q4 2018 Jan 25, 2019	SELL	$73.66 - $82.02 $206,984 - $230,476	-2,810 Reduced 5.47%	48,540 $4.17 Million
Q3 2018 Oct 17, 2018	SELL	$66.94 - $77.43 $94,720 - $109,563	-1,415 Reduced 2.68%	51,350 $4.42 Million
Q2 2018 Jul 06, 2018	BUY	$64.91 - $73.36 $59,976 - $67,784	924 Added 1.78%	52,765 $4.06 Million
Q1 2018 Apr 16, 2018	BUY	$70.39 - $84.15 $61,591 - $73,631	875 Added 1.72%	51,841 $4.2 Million
Q4 2017 Jan 29, 2018	BUY	$72.33 - $77.64 $3.69 Million - $3.96 Million	50,966	50,966 $4.42 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Account

Stonebridge Capital Management Inc Novartis Ag Transaction History